We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chinese Community Smoking Cessation Project

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00139516
First Posted: August 31, 2005
Last Update Posted: March 13, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
University of California, San Francisco
  Purpose

The study has two objectives/aims:

Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and

Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months


Condition Intervention
Cardiovascular Diseases Heart Diseases Lung Diseases Diabetes Mellitus Chronic Obstructive Pulmonary Disease Behavioral: self-help Drug: nicotine replacement therapy Behavioral: smoking cessation

Study Type: Interventional
Study Design: Allocation: Randomized
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Study Start Date: September 2001
Study Completion Date: August 2007
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • having smoked a cigarette, cigar, or tobacco pipe during the 3 months preceding the baseline interview
  • reside in the San Francisco Bay Area at baseline
  • must be fluent in either English or Chinese (Mandarin or Cantonese)
  • be 18 and over in age and
  • not currently engaging in assisted smoking cessation efforts

Exclusion criteria

  • unable to speak English or Chinese
  • too ill to participate, or not willing to participate in smoking cessation effort
  • pregnancy
  • major psychiatric illness not under control/treatment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00139516


Sponsors and Collaborators
University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Candice Wong University of California at San Francisco
  More Information

ClinicalTrials.gov Identifier: NCT00139516     History of Changes
Other Study ID Numbers: 247
R01HL069363 ( U.S. NIH Grant/Contract )
First Submitted: August 29, 2005
First Posted: August 31, 2005
Last Update Posted: March 13, 2014
Last Verified: March 2014

Additional relevant MeSH terms:
Diabetes Mellitus
Lung Diseases
Cardiovascular Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Heart Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Respiratory Tract Diseases
Nicotine
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action